Evidence map›Paper›PMID 35743774›Full record

ArticleJournal of personalized medicine2022

The Greek Collaborative Long COVID Study: Non-Hospitalized and Hospitalized Patients Share Similar Symptom Patterns.

Martha-Spyridoula Katsarou, Eleni Iasonidou, Alexander Osarogue, Efthymios Kalafatis, Maria Stefanatou, Sofia Pappa, Stylianos Gatzonis, Anastasia Verentzioti, Pantelis Gounopoulos, Christos Demponeras and 8 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05855356 (The Long-CoviD Patients Causal Diagnosis and Rehabilitation Randomized Feasibility Controlled Trial in Patients With Dysautonomia), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05855356 naunknown statusnot on this mapstarted 2023, after this paper: background citation

The Long-CoviD Patients Causal Diagnosis and Rehabilitation Randomized Feasibility Controlled Trial in Patients With Dysautonomia: the LoCoDiRe-Dys Study

TypeinterventionalSponsorEvangelismos HospitalRan2023 to 2024Enrolled50ConditionsPost-Acute COVID-19 Syndrome, DysautonomiaArmsRehabilitation, Standard of Care
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Novel Advancements in COVID-19 and Neuroscience.Journal of personalized medicine · 2024
    Article
  5. Article
  6. Article
  7. Accessing Care Services for Long COVID Sufferers in Alberta, Canada: A Random, Cross-Sectional Survey Study.International journal of environmental research and public health · 2023
    Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Martha-Spyridoula KatsarouResearch Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Zografou, Greece.
Eleni IasonidouLong COVID Greece Patient Society, 57010 Thessaloniki, Greece.
Alexander OsarogueInstitute for Social and Economic Sciences, School of Economics E.H.E. Europa Hochschule EurAka, 4106 Therwil, Switzerland.
Efthymios KalafatisLong COVID Greece Patient Society, 57010 Thessaloniki, Greece.
Maria StefanatouMedical School, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Sofia PappaDepartment of Brain Sciences, Imperial College London, London W6 8RF, UK.ORCID 0000-0002-6303-1547
Stylianos GatzonisMedical School, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Anastasia VerentziotiMedical School, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Pantelis Gounopoulos2nd Cardiology Department, "Evangelismos" Hospital, 10676 Athens, Greece.
Christos DemponerasGeneral Intensive Care Unit, Thoracic Diseases General Hospital Sotiria, 11527 Athens, Greece.
Eleni Konstantinidou2nd Cardiology Department, "Evangelismos" Hospital, 10676 Athens, Greece.
Nikolaos DrakoulisResearch Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Zografou, Greece.ORCID 0000-0002-7545-8089
Andreas AsimakosMedical School, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Archontoula AntonoglouMedical School, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Aspasia MavronasouMedical School, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Stavroula SpetsiotiMedical School, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Anastasia KotanidouMedical School, National and Kapodistrian University of Athens, 15784 Athens, Greece.ORCID 0000-0002-2508-500X
Paraskevi KatsaounouMedical School, National and Kapodistrian University of Athens, 15784 Athens, Greece.ORCID 0000-0002-8736-619X
National and Kapodistrian University of Athens · GREvangelismos Hospital · GRImperial College London · GBSotiria General Hospital · GRUniversity of Thessaly · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long COVID-19 syndrome refers to persisting symptoms (>12 weeks) after the initial coronavirus infection and is estimated to affect 3% to 12% of people diagnosed with the disease globally. Aim: We conducted a collaborative study with the Long COVID patient organization in Greece, in order to estimate the characteristics, symptoms, and challenges these patients confront. Methods: Data were collected from 208 patients using unstructured qualitative free-text entries in an anonymized online questionnaire. Results: The majority of respondents (68.8%) were not hospitalized and reported lingering symptoms (66.8%) for more than six months. Eighteen different symptoms (fatigue, palpitations, shortness of breath, parosmia, etc.) were mentioned in both hospitalized and community patients. Awareness of Long COVID sequelae seems to be low even among medical doctors. Treatment options incorporating targeted rehabilitation programs are either not available or still not included inthe management plan of Long COVID patients. Conclusions: Patients infected with coronavirus with initial mild symptoms suffer from the same persistent symptoms as those who were hospitalized. Long COVID syndrome appears to be a multi-systemic entity and a multidisciplinary medical approach should be adopted in order to correctly diagnose and successfully manage these patients.

Indexed as

Long COVIDpost-acute COVID (PACS)post-acute sequelae of COVID-19 (PASC)post-COVID

Identifiers

PMID35743774
PMCPMC9224912
OpenAlexW4283010519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.